Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Healthcare
Create a narrative
InfuSystem Holdings
NYSEAM:INFU Community
1
Narratives
written by author
0
Comments
on narratives written by author
5
Fair Values set
on narratives written by author
Create a narrative
InfuSystem Holdings
Popular
Undervalued
Overvalued
InfuSystem Holdings
WA
Analyst Price Target
Consensus Narrative from 4 Analysts
New Partnerships With Smith & Nephew And Sanara MedTech Will Strengthen Future Prospects
Key Takeaways New distribution agreements and partnerships are expected to drive revenue growth and improve margins. Focus on less capital-intensive revenue sources aims to sustain future growth and enhance net margins.
View narrative
US$14.13
FV
45.8% undervalued
intrinsic discount
9.28%
Revenue growth p.a.
Set as Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Your Valuation for
INFU
InfuSystem Holdings
Your Fair Value
US$
Current Price
US$7.65
11.0% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-19m
200m
2015
2018
2021
2024
2025
2027
2030
Revenue US$200.3m
Earnings US$2.2m
Advanced
Set as Fair Value